Login
Home / 300142.SZ : SHZ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Walvax Biotechnology Co., Ltd.

¥13.01 +$1.68 (+14.83%)
SHZ · 15 Sep 2026 07:04 UTC
Previous Close
¥13.39
Day Range
¥13¥13.31
Year Range
¥10.88¥16.97
Market Cap
20.81B
AVG Volume
96.07M
Trailing/Forward PE
110.35/144.56
PEG ratio
0.55
Dividend Yield
1.19%
Next Earnings Date
2026-10-23
Primary Exchange
Shenzhen Stock ExchangeCN
Revenue (CNY)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
-0.1-0.0500.050.124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
0200M400M600M800MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-1%0%1%2%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.050.10.15Apr 15Jul 19Sep 20May 21Apr 22May 23May 24May 25Jan 26Jun 26
Book Value Per Share (CNY)
0246824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
050010001500med 149.62Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-1%0%1%2%3%4%med 0.84%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
4681012med 7.32Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
050100150med 35.15Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
1020304050med 23.25Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
11.522.533.5med 1.76Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Walvax Biotechnology Co., Ltd.
300142.SZ
Stockpicker

Video analysis: 300142.SZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.